Alternative Data for Cytek BioSciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 31 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 64,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 12 | Sign up | Sign up | Sign up |
| Facebook Followers | 863 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 301 | Sign up | Sign up | Sign up |
| X Followers | 1,237 | Sign up | Sign up | Sign up |
| X Mentions | 9 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 2,030 | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 35 | Sign up | Sign up | Sign up |
| Linkedin Employees | 444 | Sign up | Sign up | Sign up |
About Cytek BioSciences
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
| Price | $3.68 |
| Target Price | Sign up |
| Volume | 966,111 |
| Market Cap | $532M |
| Year Range | $3.38 - $5.88 |
| Dividend Yield | 0% |
| Analyst Rating | 50% buy |
| Industry | Medical Devices |
In the news
 |
Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 14 - SeekingAlpha |
|
Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 14 - SeekingAlpha |
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in MedtechMay 13 - GlobeNewswire |
|
 |
Deep peptide recognition profiling decodes TCR specificity and enables disease-associated antigen discoveryMay 12 - Nature.com |
Toxoplasma IMC1 is a central component of the subpellicular network and plays critical roles in parasite morphology, replication, and infectivityMay 11 - Plos.org |
|
 |
Androgen loss accelerates brain tumour growth via HPA axis activationMay 5 - Nature.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '26 | 44M | 23M | 21M | -19M | -18M | |
| Q4 '25 | 62M | 29M | 33M | -44M | -260,000 | -0.287 |
| Q3 '25 | 52M | 25M | 28M | -5.5M | -4.2M | -0.040 |
| Q2 '25 | 46M | 22M | 24M | -5.6M | -3.4M | -0.040 |
| Q1 '25 | 41M | 21M | 20M | -11M | -8.1M | -0.027 |
Insider Transactions View All
| McCombe William D. filed to buy 55,746 shares at $2.8. June 3 '25 |
| Yan Ming filed to sell 5,988,502 shares at $5.9. April 23 '24 |
| Yan Ming filed to sell 6,008,502 shares at $7. April 11 '24 |
| Yan Ming filed to sell 6,008,902 shares at $7. April 11 '24 |
| Yan Ming filed to sell 6,010,402 shares at $6.7. March 19 '24 |
Similar companies
Read more about Cytek BioSciences (CTKB) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Cytek BioSciences
The Market Cap of Cytek BioSciences is $532M.
Currently, the price of one share of Cytek BioSciences stock is $3.68.
The CTKB stock price chart above provides a comprehensive visual representation of Cytek BioSciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cytek BioSciences shares. Our platform offers an up-to-date CTKB stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Cytek BioSciences (CTKB) does not offer dividends to its shareholders. Investors interested in Cytek BioSciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Cytek BioSciences are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
